Medication info
Glycita Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)

Glycita Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTablet경구
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
(주)동구바이오제약
Appearance
Bright brown, round, biconvex film-coated tablets
Packaging
28 tablets/box [14 tablets/PTPX2]
Approval status
Active

MFDS item code 202102397 · Approved 2021.03.17 · Insurance code 657308560

Summary

Main use
Improvement of blood sugar control in type 2 diabetes
Who takes it
Adults
Adult dose
This drug is administered once daily at a dose of 100 mg, whether used alone or in combination, with a maximum daily dose of 100 mg. It can be taken regardless of meals. In patients with renal impairment, dose adjustment is required based on renal function. - For mild renal impairment (eGFR 60–90 mL/min/1.73 m2): No dose adjustment necessary - For moderate renal impairment (eGFR 45–60 mL/min/1.73 m2): Dose adjustment

Ingredients

Manufacturer
(주)동구바이오제약

Efficacy & effects

Improvement of blood sugar control in type 2 diabetes

  • Type 2 diabetes
  • difficulty in blood sugar control
View approved original text

This medication is used together with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It may be administered alone to patients starting treatment, and when blood sugar control is difficult, it can be used in combination with metformin or other hypoglycemic agents. Additionally, this drug can be added to existing therapies with sulfonylureas, metformin, thiazolidinediones, or insulin if those monotherapies are ineffective. In cases where complex pharmacotherapy is required, this drug can enhance blood sugar control when included in combination therapy. Therefore, this medication is designed to improve blood sugar management in various treatment scenarios.

How to take

Adult dose

This drug is administered once daily at a dose of 100 mg, whether used alone or in combination, with a maximum daily dose of 100 mg. It can be taken regardless of meals. In patients with renal impairment, dose adjustment is required based on renal function. - For mild renal impairment (eGFR 60–90 mL/min/1.73 m2): No dose adjustment necessary - For moderate renal impairment (eGFR 45–60 mL/min/1.73 m2): Dose adjustment

Precautions

This drug may cause severe hypersensitivity reactions; thus, if an allergic reaction is suspected, use should be immediately discontinued and medical consultation should be sought. Acute pancreatitis may occur; thus, if symptoms such as abdominal pain, nausea, or vomiting appear, prompt medical attention is necessary. It is not safe to use this drug in patients with type 1 diabetes or diabetic ketoacidosis. Patients with impaired renal function should have their dosing adjusted, and regular renal function testing is important. Hypoglycemic symptoms may occur during treatment; therefore, monitoring blood glucose carefully is necessary, especially when taken in conjunction with insulin or sulfonylureas. If severe joint pain or skin blisters arise, discontinue use of this drug immediately and inform a healthcare professional. Pregnant or breastfeeding women should avoid using this drug, and its safety in children or adolescents under 18 years has not been established. Elderly patients may experience decreased renal function, so dose adjustments and regular renal function testing are required. In cases of overdose, symptomatic treatment, including the removal of the drug from the gastrointestinal tract, may be necessary, and some may be removed by dialysis. Drug interactions are minimal; however, caution is required when used with digoxin or cyclosporine. This drug is proven to have cardiovascular safety, but if any unusual symptoms arise during administration, immediate consultation with a healthcare professional is advised.

Side effects and when to seek care immediately

Serious side effects

  • Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor → severe allergic reaction
  • Severe rash with high fever, blisters, skin peeling, mucosal pain in mouth/eyes → severe skin adverse reaction
  • Shortness of breath or difficulty breathing, asthma attacks, cough accompanied by fever and respiratory issues → respiratory problems
  • Skin or eyes turning yellow (jaundice), extreme lethargy → liver abnormalities (jaundice)
  • Sudden

Mild side effects

  • Upper respiratory infection
  • nasopharyngitis
  • headache
  • constipation
  • vomiting
  • myalgia
  • limb pain
  • back pain
  • pruritus
  • thrombocytopenia
Show 9 more
  • diarrhea
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • elevated low-density lipoprotein
  • hyperglycemia
  • weight loss
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent air exposure and is best kept at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness.

Appearance and packaging

Appearance

Bright brown, round, biconvex film-coated tablets

Package unit

28 tablets/box [14 tablets/PTPX2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.